Shandong Luye Drug Patent Portfolio
Shandong Luye owns 1 orange book drug protected by 5 US patents Given below is the list of Shandong Luye's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US10098882 | Risperidone sustained release microsphere composition | 10 Apr, 2032 | Active |
US10406161 | Risperidone sustained release microsphere composition | 10 Apr, 2032 | Active |
US11110094 | Risperidone sustained release microsphere composition | 10 Apr, 2032 | Active |
US9446135 | Risperidone sustained release microsphere composition | 10 Apr, 2032 | Active |
US9532991 | Risperidone sustained release microsphere composition | 10 Apr, 2032 | Active |
Latest Legal Activities on Shandong Luye's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Shandong Luye.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 8th Year, Large Entity | 03 Jul, 2024 | US9532991 |
Payment of Maintenance Fee, 8th Year, Large Entity | 19 Mar, 2024 | US9446135 |
Payment of Maintenance Fee, 4th Year, Large Entity | 10 Mar, 2023 | US10406161 |
Payment of Maintenance Fee, 4th Year, Large Entity | 28 Mar, 2022 | US10098882 |
Patent Issue Date Used in PTA Calculation
Critical
| 07 Sep, 2021 | US11110094 |
Recordation of Patent Grant Mailed
Critical
| 07 Sep, 2021 | US11110094 |
Email Notification
Critical
| 19 Aug, 2021 | US11110094 |
Issue Notification Mailed
Critical
| 18 Aug, 2021 | US11110094 |
Dispatch to FDC | 05 Aug, 2021 | US11110094 |
Application Is Considered Ready for Issue
Critical
| 05 Aug, 2021 | US11110094 |
Issue Fee Payment Verified
Critical
| 04 Aug, 2021 | US11110094 |
Issue Fee Payment Received
Critical
| 04 Aug, 2021 | US11110094 |
Email Notification
Critical
| 05 May, 2021 | US11110094 |
Mail Notice of Allowance
Critical
| 05 May, 2021 | US11110094 |
Electronic Review
Critical
| 05 May, 2021 | US11110094 |
Shandong Luye's Family Patents
Shandong Luye Drug List
Given below is the complete list of Shandong Luye's drugs and the patents protecting them.
1. Rykindo
Rykindo is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US10098882 | Risperidone sustained release microsphere composition |
10 Apr, 2032
(7 years from now)
| Active |
US10406161 | Risperidone sustained release microsphere composition |
10 Apr, 2032
(7 years from now)
| Active |
US11110094 | Risperidone sustained release microsphere composition |
10 Apr, 2032
(7 years from now)
| Active |
US9446135 | Risperidone sustained release microsphere composition |
10 Apr, 2032
(7 years from now)
| Active |
US9532991 | Risperidone sustained release microsphere composition |
10 Apr, 2032
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rykindo's drug page